These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31486735)

  • 21. Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids.
    Tantisira KG; Lake S; Silverman ES; Palmer LJ; Lazarus R; Silverman EK; Liggett SB; Gelfand EW; Rosenwasser LJ; Richter B; Israel E; Wechsler M; Gabriel S; Altshuler D; Lander E; Drazen J; Weiss ST
    Hum Mol Genet; 2004 Jul; 13(13):1353-9. PubMed ID: 15128701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exhaled nitric oxide monitoring does not reduce exacerbation frequency or inhaled corticosteroid dose in paediatric asthma: a randomised controlled trial.
    Pike K; Selby A; Price S; Warner J; Connett G; Legg J; Lucas JS; Peters S; Buckley H; Magier K; Foote K; Drew K; Morris R; Lancaster N; Roberts G
    Clin Respir J; 2013 Apr; 7(2):204-13. PubMed ID: 22747899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional polymorphism in CTLA4 gene influences the response to therapy with inhaled corticosteroids in Slovenian children with atopic asthma.
    Berce V; Potocnik U
    Biomarkers; 2010 Mar; 15(2):158-66. PubMed ID: 19895365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 17q21 variant increases the risk of exacerbations in asthmatic children despite inhaled corticosteroids use.
    Farzan N; Vijverberg SJ; Hernandez-Pacheco N; Bel EHD; Berce V; Bønnelykke K; Bisgaard H; Burchard EG; Canino G; Celedón JC; Chew FT; Chiang WC; Cloutier MM; Forno E; Francis B; Hawcutt DB; Herrera-Luis E; Kabesch M; Karimi L; Melén E; Mukhopadhyay S; Merid SK; Palmer CN; Pino-Yanes M; Pirmohamed M; Potočnik U; Repnik K; Schieck M; Sevelsted A; Sio YY; Smyth RL; Soares P; Söderhäll C; Tantisira KG; Tavendale R; Tse SM; Turner S; Verhamme KM; Maitland-van der Zee AH
    Allergy; 2018 Oct; 73(10):2083-2088. PubMed ID: 29885281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of VEGF polymorphisms with childhood asthma, lung function and airway responsiveness.
    Sharma S; Murphy AJ; Soto-Quiros ME; Avila L; Klanderman BJ; Sylvia JS; Celedón JC; Raby BA; Weiss ST
    Eur Respir J; 2009 Jun; 33(6):1287-94. PubMed ID: 19196819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
    Chauhan BF; Chartrand C; Ducharme FM
    Cochrane Database Syst Rev; 2012 Dec; 12():CD009611. PubMed ID: 23235678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of symptom control with changes in lung function, bronchial hyperresponsiveness, and exhaled nitric oxide after inhaled corticosteroid treatment in children with asthma.
    Park GM; Han HW; Kim JY; Lee E; Cho HJ; Yoon J; Hong SJ; Yang SI; Yang HJ; Yu J
    Allergol Int; 2016 Oct; 65(4):439-443. PubMed ID: 27160342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated fractional exhaled nitric oxide (FeNO) is a clinical indicator of uncontrolled asthma in children receiving inhaled corticosteroids.
    Yin SS; Liu H; Gao X
    Int J Clin Pharmacol Ther; 2017 Jan; 55(1):66-77. PubMed ID: 27443657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation Between Fractional Exhaled Nitric Oxide Levels and Efficacy of Inhaled Corticosteroids in Children With Bronchial Asthma.
    Gao SJ; Ge YP; Zhang CJ
    Am J Ther; 2018; 25(6):e617-e625. PubMed ID: 26990963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
    Ni CM; Greenstone IR; Ducharme FM
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids.
    Kanemitsu Y; Matsumoto H; Izuhara K; Tohda Y; Kita H; Horiguchi T; Kuwabara K; Tomii K; Otsuka K; Fujimura M; Ohkura N; Tomita K; Yokoyama A; Ohnishi H; Nakano Y; Oguma T; Hozawa S; Nagasaki T; Ito I; Oguma T; Inoue H; Tajiri T; Iwata T; Izuhara Y; Ono J; Ohta S; Tamari M; Hirota T; Yokoyama T; Niimi A; Mishima M
    J Allergy Clin Immunol; 2013 Aug; 132(2):305-12.e3. PubMed ID: 23791506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GLCCI1 and STIP1 variants are associated with asthma susceptibility and inhaled corticosteroid response in a Tunisian population.
    Salhi M; Lahmar O; Salah MO; Banić I; Binghao B; Malik W; Hamzaoui K; Turkalj M; Hamzaoui A
    J Asthma; 2021 Feb; 58(2):197-206. PubMed ID: 31516081
    [No Abstract]   [Full Text] [Related]  

  • 33. Daily versus as-needed corticosteroids for mild persistent asthma.
    Boushey HA; Sorkness CA; King TS; Sullivan SD; Fahy JV; Lazarus SC; Chinchilli VM; Craig TJ; Dimango EA; Deykin A; Fagan JK; Fish JE; Ford JG; Kraft M; Lemanske RF; Leone FT; Martin RJ; Mauger EA; Pesola GR; Peters SP; Rollings NJ; Szefler SJ; Wechsler ME; Israel E;
    N Engl J Med; 2005 Apr; 352(15):1519-28. PubMed ID: 15829533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of STIP1 and GLCCI1 polymorphisms on the risk of childhood asthma and inhaled corticosteroid response in Chinese asthmatic children.
    Huang J; Hu X; Zheng X; Kuang J; Liu C; Wang X; Tang Y
    BMC Pulm Med; 2020 Nov; 20(1):303. PubMed ID: 33208131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do children with stable asthma benefit from addition of montelukast to inhaled corticosteroids: randomized, placebo controlled trial.
    Stelmach I; Ożarek-Hanc A; Zaczeniuk M; Stelmach W; Smejda K; Majak P; Jerzynska J; Anna J
    Pulm Pharmacol Ther; 2015 Apr; 31():42-8. PubMed ID: 25640020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenetic study of the effects of NK2R G231E G>A and TBX21 H33Q C>G polymorphisms on asthma control with inhaled corticosteroid treatment.
    Ye YM; Lee HY; Kim SH; Jee YK; Lee SK; Lee SH; Park HS
    J Clin Pharm Ther; 2009 Dec; 34(6):693-701. PubMed ID: 20175803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults.
    Petsky HL; Cates CJ; Li AM; Kynaston JA; Turner C; Chang AB
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006340. PubMed ID: 18425949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids.
    Tantisira KG; Hwang ES; Raby BA; Silverman ES; Lake SL; Richter BG; Peng SL; Drazen JM; Glimcher LH; Weiss ST
    Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18099-104. PubMed ID: 15604153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma.
    Fritscher LG; Rodrigues MT; Zamel N; Chapman KR
    Respir Med; 2009 Feb; 103(2):296-300. PubMed ID: 18805684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.